PolyPid Ltd

Here is the public summary page for PolyPid Ltd. Please login to see the complete information for PolyPid Ltd including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how PolyPid Ltd stacks up relative to its peers.

Darwin Score	+6
Ticker	PYPD
Latest Price	3.36 USD as of close on 31-Jul-2025
3 Month price range	2.43 to 3.74 USD
Market Capitalisation	35.67Mn USD
Country	Israel
Region	Asia
Economic Sector	Health Care
Business Sector	Pharmaceuticals, Biotechnology & Life Sciences
Industry	Biotechnology
Sub-Industry	Biotechnology
Description	PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel. See More ...
Company URL	https://www.polypid.com

See Darwins Full Analysis for PolyPid Ltd

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for PolyPid Ltd. Further information and full detail is available when you login.

TMA Part	Focus of Analysis	TMA Score
Price	Analysis of performance, trend, RSI, OBV and moving averages	+17
Sentiment	News and Candle Patterns.	0
Fundamentals	Analyst Ratings, Valuation and Dividend analysis.	+2
Flow	Institutional, Fund and Insider buying and selling.	+1
Models	Forecast models.	-14